Home - National Multiple Sclerosis Society

Skip to navigation Skip to content
National MS Society
Email not displaying correctly? View it in your browser.
eNews - September 2010 - National MS Society
FDA approves fingolimod for MS

First oral MS treatment to reduce disease activity

On Tuesday, September 21, the U.S. Food and Drug Administration approved fingolimod capsules (Gilenya, Novartis International AG) for reducing the frequency of relapses and delaying the accumulation of physical disability in relapsing forms of MS, making it the first oral disease-modifying therapy for the treatment of MS. According to Novartis, the drug will be available for prescription in coming weeks.

Read more here

 Find us on Facebook 

YouTube MySpace Twitter



Andrei Floroiu

Andrei Floroiu and Fly for MS


 The 22 top Society scholarship recipients

Back to School: The Society’s Scholarship Program


Study revealse clues to MS progression Society-funded study reveals clues to MS progression

A study of more than 5,000 people with MS pinpointed male gender or symptoms at onset, such as spasticity, as factors associated with a faster progression from relapsing-remitting MS to secondary-progressive MS. The study was funded by the National MS Society, the MS Society of Canada and others.

Read more


Touchdown for MS Touchdown for MS

John and Sallie Prince’s daughter Leslie was diagnosed with MS in the 1970s. For the last 26 years, the Princes have raised about $300,000 for the MS movement through auctioning footballs autographed by Heisman winners.

Meet the Princes and make a bid


Accelerate our progressAccelerate our progress
Your gift today will continue to accelerate promising research, fund life-changing programs, and provide financial assistance for people with MS.

Donate Now




This communication is partially sponsored through the generous support of Bayer HealthCare and Biogen Idec, and Teva Neuroscience, Inc.

eNews Bayer HealthCare    MS Active Source   Teva Pharmaceuticals

More MS News
Sep. 16: Study suggests functional electrical stimulation device improves mobility in people with MS and foot drop
Aug. 2: Investigators recruiting worldwide for trial of another oral MS disease-modifier
Read more about these and other recent reports
Shop at the Society Store       Join a Walk MS Event       Join a Bike MS Event

National MS Society | View as Web page | Subscribe | Legal Notice/Privacy Policy | Email Preferences | Unsubscribe

MS stops people from moving. The National MS Society exists to make sure it doesn’t. We are a collective of passionate individuals, moving together to create a world free of MS.

Please do not reply to this email as we are unable to quickly respond to messages sent to this address. To receive information about living with MS, Bike MS or Walk MS — or to contact National MS Society staff in your area — please
visit our Web site.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at http://www.nationalmssociety.org/ or 1-800-344-4867.

National Multiple Sclerosis Society | 733 Third Avenue | New York, NY | 10017

This message was sent to . To ensure that you continue to receive our emails, please add us to your address book.